AstraZeneca Investor Day Presentation Deck
September 2022, 49 slides
  1. AstraZeneca
  2. Related Decks
  3. Investor Day Presentation Decks
rare disease | AstraZeneca
forward looking statements | AstraZeneca
rare disease investor event agenda | AstraZeneca
strategy | AstraZeneca
| AstraZeneca
rare disease in years | AstraZeneca
rare disease strategic priorities | AstraZeneca
rare disease approved medicines medicines | AstraZeneca
rare disease | AstraZeneca
complement | AstraZeneca
broad in complement biology | AstraZeneca
foundation in terminal complement inhibition | AstraZeneca
foundation in terminal complement inhibition | AstraZeneca
establishing as the new standard of care | AstraZeneca
compelling durable data in | AstraZeneca
phase confirms leadership in it | AstraZeneca
durable efficacy in | AstraZeneca
phase confirms leadership in | AstraZeneca
indication expansion will continue | AstraZeneca
geographic expansion | AstraZeneca
supports further indication expansion | AstraZeneca
inhibition in as | AstraZeneca
expanding into proximal complement inhibition | AstraZeneca
oral factor portfolio | AstraZeneca
demonstrated for factor inhibitors in | AstraZeneca
portfolio approach | AstraZeneca
portfolio approach in | AstraZeneca
portfolio approach in go | AstraZeneca
first step to expand reach in | AstraZeneca
portfolio approach in and | AstraZeneca
innovating in new complement frontiers | AstraZeneca
beyond complement | AstraZeneca
expanding beyond complement | AstraZeneca
a | AstraZeneca
next generation | AstraZeneca
amyloidosis | AstraZeneca
amyloidosis portfolio strategy | AstraZeneca
in amyloidosis | AstraZeneca
expanding beyond complement | AstraZeneca
expansion | AstraZeneca
geographic expansion | AstraZeneca
china represents significant opportunity for rare disease | AstraZeneca
scientific bridges | AstraZeneca
accelerating discovery and research | AstraZeneca
three genomic medicine projects underway | AstraZeneca
summary | AstraZeneca
rare disease be | AstraZeneca
a session | AstraZeneca
| AstraZeneca
See More
AstraZeneca
Investor Day Presentation Decks
Drug Manufacturers—General Decks
Healthcare Decks
Explore Topics
Medicine
Monotherapy
Rare disease
Recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
See all presentations by AstraZeneca (27 decks)
Related decks
Absci
Investor Conference
January 2023
uBiome
Start Up
June 2017
Invitae
Results
August 2023
Tivic Health Systems
Investor Presentation
October 2022
Alkermes
Results
June 2022
AbCellera
Results
August 2023
Nuvectis Pharma
Investor Presentation
July 2023
Evotec
Investor Presentation
July 2022
Recent decks by AstraZeneca
See all presentations (27 decks)
Results
February 2024
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Absci
Investor Conference
January 2023
uBiome
Start Up
June 2017
Invitae
Results
August 2023
Tivic Health Systems
Investor Presentation
October 2022
Alkermes
Results
June 2022
AbCellera
Results
August 2023
Nuvectis Pharma
Investor Presentation
July 2023
Evotec
Investor Presentation
July 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io